Skip to main content
VCbacked
Log inGet Started

Alume Biosciences

San Diego, United States

Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.

$3.6M raised
Oct 2025
Venture - Series Unknown
BiotechnologyLife ScienceMedical

Top Investors

National Institute of Neurological Disorders and StrokeDaniel M. BradburyChrysa Mineo

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alume Biosciences

How much funding has Alume Biosciences raised?
Alume Biosciences has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Who are Alume Biosciences's investors?
Alume Biosciences's investors include National Institute of Neurological Disorders and Stroke, Daniel M. Bradbury, Chrysa Mineo.
Where is Alume Biosciences headquartered?
Alume Biosciences is headquartered in San Diego, United States.
What does Alume Biosciences do?
Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.
What stage is Alume Biosciences at?
Alume Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alume Biosciences — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/alume-biosciences. Accessed July 1, 2026.
APA
VCBacked. (2025). Alume Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/alume-biosciences
Wikipedia (cite web)
{{cite web |title=Alume Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/alume-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver
Rapport Therapeutics
Boston
Neuroglee Therapeutics
Singapore
Living In Silico Inc.
Brampton
Navrogen
Philadelphia
MY01
Montréal